2nd Quarter - Report
THE MCMANUS GROUP for AMGEN
Firm
Client
Income
$60,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Access and reimbursement for Part B and Part D drugs. Opposition to step therapy requirement in Medicare Advantage. Lobbied against the International Pricing Index model (83 FR 54546). The Prescription Drug STAR Act, H.R. 2113.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTINA HOCHUL New | — |
| JOHN MCMANUS | — |
| BARRETT THORNHILL | — |
Health Issues HCR
Support for 340B reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MCMANUS | — |
| BARRETT THORNHILL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.